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Abstract 
The study aimed to evaluate  the prevalence of Yokenella regensburgei  and to determine the phenotypic 
resistance patterns of this bacterium.A total of  300 urine  samples were collected during a period  intervals from 
February till July of the year 2013 from patients complained from urinary tract infections visited An- Najaf  
province  Hospitals. The samples in all had been cultured on MacConkey agar where the results revealed that 
there were 250 of isolates  lactose  fermentative  versus to  50 were lactose non fermentative .The lactose non 
fementative isolates then  subjected  to further identification and  the  phenotypic resistance  patterns   by Vitek-2 
system had been conducted. The results  revealed  as first  report  identification of Yokenella regensburgei  as 
agent of urinary tract infection with occurrence rate of 0.33% which might indicated the risk of related 
underlying diseases . the results of antibiotic  susceptibility showed that the bacterium was  sensitive to most 
screened  antibiotics beside nitrofurantoin, tetracycline and trimethoprim/sulfamethoxazole  shown activity 
against the  bacterium. 
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1.  Introduction 
Yokenella regensburgei is one of a number of  rarely encountered members of the family Enterobacteriaceae that 
infrequently been isolated from humans. Formerly this bacterium  identified as NIH biogroup 9 by the National 
Institutes of Health in Japan (Kosako et al., 1984) also as enteric group 45 by the Centers for Disease Control 
and Prevention (Hickman-Brenner et al.,1985), biochemically it greatly resembles Hafnia alvei.  Kosako et al. 
(1984) suggested the name Y. regensburgei for this new genus and species while the Centers for Disease Control 
and Prevention proposed the name "Koserella trabulsii" for enteric group 45 (Hickman-Brenner et al.,1985).So  
it was recognized that Y. regensburgei and "K. trabulsii" are objective synonyms (Kosako et al., 1987) and 
Kosako and Sakazaki (1991) proposed that the name Y. regensburgei had priority over "K trabulsii" upon the 
basis of rule  of the Bacteriological Code. In 1991, the Centers for Disease Control and Prevention approved that 
Y. regensburgei had priority upon the basis of prior publication and has since dropped the use of the name "K. 
trabulsii" (McWhorter et al.,1991). Yokenella regensburgei is an opportunistic human pathogen and is the only 
species of the genus Yokenella within the family Enterobacteriaceae (Stock et al., 2004; Abbott  and  Janda, 
1994). Y. regensburgei has been recovered from the intestinal tracts of insects, well water, and a number of 
anatomic sites in humans, including wounds of the limbs, the upper respiratory tract, urine, feces, and knee fluid 
(Hickman-Brenner et al.,1985, Kosako et al., 1984).  
 
2. Materials and methods 
2.1. Collection of samples  
The  urine samples from  patients complained from urinary tract infections were collected aseptically then these 
samples transfered as soon as possible to laboratory to avoid contamination, the samples subjected to different 
culturing and biochemical tests. 
 
2.2. Isolation  and  Identification  
The identified isolates  which had been cultured on Macconky agar, MacConkey's agar medium is specially 
made to distinguish lactose non-fermenting (pale or colorless colonies)  from lactose fermenting bacteria (pink to 
red colonies) furthermore the identification to  species level confirmed by using automated Vitek 2 system which 
was briefly described. Suspension was prepared according to the manufacturer’s recommendations of 
bioMérieux company by transferring sufficient number of colonies from overnight pure culture by swab and 
suspending the microorganism in 3.0 ml of sterile saline in a can tube . Turbidity had been adjusted to be from 
0.5 to 0.63 using a turbidity meter called DensiChek. The same suspension was used in identification and 
antibiogram testing with VITEK-2 compact system. The identified. isolates were confirmed with the automated 
VITEK-2 compact system by using GN-ID cards (BioMérieux Company). This can briefly described as 
folllowing: 
GN-ID cards were inoculated with microorganism suspensions using an integrated vacuum apparatus. 
A test tube containing the microorganism suspension was placed into a special rack (cassette) and the 
identification card is placed in the neighboring slot while inserting the transfer tube into the corresponding 
Journal of Biology, Agriculture and Healthcare                                                                                                                                www.iiste.org 
ISSN 2224-3208 (Paper)  ISSN 2225-093X (Online) 
Vol.5, No.7, 2015 
 
75 
suspension tube.The cassette can accommodate up to 10 tests with VITEK-2 compact system. The filled cassette 
was placed manually into a vacuum chamber station. After the vacuum was applied and air was re-introduced 
into the station, the organism suspension was forced through the transfer tube into micro-channels that fill all the 
test wells.  
 
2.3. Minimum Inhibitory Concentration (MIC) by Vitek system.  
Antibiotic susceptibility testing was performed with the automated VITEK-2 compact system based on MIC 
technique determination by using AST-N82 cards. This card contained the following antibiotics, Ampicillin, 
Amoxicillin/ clavulanic acid, Ampicillin/ sulbactam , piperacillin/tazobactam, cefazolin, cefepime, 
ceftazidime,ceftriaxone, aztreonam, imipenem, meropenem, amikacin, tobramycin, gentamicin, ciprofloxacin, 
trimethoprim-sulfamethoxazole, tigecycline, nitrofurantoin. 
AST-N82 cards were inoculated in the same manner as described for VITEK-2 compact system, 
evaluation of each organism’s growth pattern in the presence of the antimicrobial in relation to growth control 
well. Several parameters based on the growth characteristics observed are used to provide appropriate input for 
MIC calculations. The MIC result must be linked to an organism identification to determine a category 
interpretation. A category interpretation of MIC will be reported according to the interpretations defined by 
Global 2012. 
 
3. Results 
The identified Y. regensburgei revealed disparity in biochemicals tests of Vitek - 2 system as shown in table (1). 
Table (1) The results of  biochemical tests of Vitek -2 system. 
Test Result 
Ala-phe-pro-arylamidase, Adonitol, L-pyrrolydonyl-arylamidase, L- arabitol, D-cellobiose, 
Glutamyl arylamidase PNA, Fermentation/ glucose, D- maltose, β- xylosidase, β- alanine – 
arylamidase PNA, L- proline- arylamidase, Palatinase, Lipase, D-sorbitol, Sucrose, D- Tagatose, 5-
Ketoguconate, Α-Glucosidase, Glycine- arylamidase, Β-N-acetyl galactosaminidase, α- 
Galactosidase, Glycine- arylamidase, Lysine decarboxylase, L-Histidine assimalation, Β- 
Glucoronidase, Glu-Gly-Arg-arylamidase, L-lactate assimilation, ELLman, L-maltate assimalation 
 
 
 
 
-VE 
H2S production, β-N-acetyl- glucosaminidase, D- glucose, Gamma-glutamyl – transferase, β- 
glucosidase, D- mannitol, D-mannose, Tyrosine- arylamidase, Urease, D-Trehalose, Citrate-Na, L-
Lactate alkalinization, Succinate alkalinization, Phosphotase, Ornithin decarboxylase, Coumorate, 
O/129 resistance({camp. Vibrio) 
 
 
+VE 
As stated in table (2) the bacterium showed differences in its susceptibility patterns where the 
bacterium was sensitive to most screened antibiotics used in Vitek 2 system on contrary the bacterium exhibited 
resitance to  Nitrofurantoin, Tetracycline, Trimethoprim / Sulfamethaxazole. 
Table (2) antibiogram  of identified Y. regensburgei to different antibiotics  tested  by Vitek 2 system.  
Antibiotic(s) MIC Interpretation 
Amikacin, Ampicillin <=2 S 
Amoxicillin/ clavulanic acid, Imipenem 4 S 
Aztreonam,Cefepime, Ceftriaxone, Gentamicin <=1  S 
Cefazolin, Piperacillin/ Tazobactam <=4 S 
Ciprofloxacin <= 0.25 S 
ESBL -VE - 
Ertapenem 1 S  
Levofloxacin 0.5 S 
Meropenem <= 0.25 S 
Nitrofurantoin 256 R 
Tetracycline < =16 R 
Trimethoprim / Sulfamethaxazole < = 320 R 
ESBL, Extended Spectrum β-Lactamase ; MIC, Minimum Inhibitory Concentration 
 
4. Discussion 
The results of this study revealed that this bacterium was motile, oxidase , indole  and methyl red were negative 
while catalase, voges proskauer, citrate utilization and urease were positive. 
Identification and biochemical properties founded on monotonous biochemical testing. The organism 
was found to be a motile which was weakly positive for catalase, oxidase-negative and able to utilize citrate 
(positive after 48 h) and had a triple sugar iron reaction of K/A with gas (indole, H2S and urease not produced). 
The non-lactose-fermenting organism was probably  identified as Salmonella enterica serovar Paratyphi A (S. 
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Paratyphi)  (Sarika et al.,2013).  Abbott and Janda (1994)  published  that both identified  Y regensburgei strains 
were oxidase negative and catalase and nitrate positive. The strain from case 1 was esculin positive and  
anaerogenic in glucose and cellobiose broths, while the strain isolated from case 2 was esculin negative and 
aerogenic in both carbohydrates. Similar differences in regards to acetate  utilization and glycerol and raffinose 
fermentation by Y. regensburgei strains were also noted in both of their surveys (Hickman-Brenner et al.,1985 ;  
Kosako et al.,1991). Abbott and Janda (1994)  going on to stated  that both identified strain of Y. regensburgei 
exhibited similarity in all biochemical tests where these strain were negative for indole , voges-proskauer, 
malonate, adonitol, dulcitol, glycerol , m-inositol,lactose ,a-ch3-glucoside raffinose, d-sorbitol, sucrose, mucate, 
lipase and Dnase while these strains were positive for citrate utilization, lysine decarboxylase , arginine 
dihydrolase , growth in KCN, glucose, L-arabinose, cellobiose, d. Mannitol, L-rhamnose, D-xylose,acetate. The 
identified bacterium was negative to Indole production , H2S production , Adonitol , Lactose, Malonate, Urease 
production , D-Sorbitol , Sucrose, Aesculin, Lipase, Arginine decarboxylase , Phenylalanine deaminase , D-
Raffinose furthermore the bacterium was positive to L-Arabinose , D-Cellobiose , ONPG, D-Glucose , D-
Maltose , D-Mannitol , Citrate, Glucose fermentation , Xylose, L-Rhamnose , Ornithine decarboxylase , Lysine 
decarboxylase (Sarika et al., 2013). The present study showed that the identified bacterium was positive for H2S 
production, β-N-acetyl- glucosaminidase, D- glucose, Gamma-glutamyl – transferase, β- glucosidase, D- 
mannitol, D-mannose, Tyrosine- arylamidase, Urease, D-Trehalose, Citrate-Na, L-Lactate alkalinization, 
Succinate alkalinization, Phosphotase, Ornithin decarboxylase, Coumorate, O/129 resistance (camp. Vibrio) 
while the babterium was negative to Ala-phe-pro-arylamidase, Adonitol, L-pyrrolydonyl-arylamidase, L- 
arabitol, D-cellobiose, Glutamyl arylamidase PNA, Fermentation/ glucose, D- maltose, β- xylosidase, β- alanine 
– arylamidase PNA, L- proline- arylamidase, Palatinase, Lipase, D-sorbitol, Sucrose, D- Tagatose, 5-
Ketoguconate, Α-Glucosidase, Glycine- arylamidase, Β-N-acetyl galactosaminidase, α- Galactosidase, Glycine- 
arylamidase, Lysine decarboxylase, L-Histidine assimalation, Β- Glucoronidase, Glu-Gly-Arg-arylamidase, L-
lactate assimilation, ELLman, L-maltate assimalation as shown in table (1). Sarika et al. (2013) mentioned that 
the antibiotic resistance pattern of identified  bacterium vary between resistance to Penicillin,  Cefoxitin,  
Colistin and sensitivity to most antibiotics embodied by Ampicillin, Amoxicillin–clavulanate, Erythromycin, 
Ceftazidime, Ceftriaxone, Ciprofloxacin, Nalidixic acid, Gentamicin, Amikacin, Netilmycin, Piperacillin–
tazobactam, Imipenem,  Ertapenem, Meropenem, Tigecycline this  was greatly agreed with the results of this 
study which revealed that the identified bacterium was resistant to Nitrofurantoin, Tetracycline, Trimethoprim / 
Sulfamethaxazole moreover this bacterium was sensitive to most screened antibiotics represented by Amikacin, 
Ampicillin, Amoxicillin/ clavulanic acid, Imipenem, Aztreonam,Cefepime, Ceftriaxone, Gentamicin, Cefazolin 
Piperacillin/ Tazobactam, Ciprofloxacin, Ertapenem, Levofloxacin, Meropenem whereas the bacterium was not 
produce extended spectrum beta lactamase. Kosako et al. (1984)  mentioned that the epidemiological and clinical 
significance of this organism is not established. Y. regensburgei has been isolated from water, wells, salad and 
the intestinal tracts of insects and reptiles. It is rarely reported to cause human infections, with only sporadic case 
reports available in the literature. It has been isolated from leg wound, blood, upper  respiratory  tract, urine, 
faecal and synovial fluid samples (Stock et al., 2004; Abbott and Janda, 1994; Kosako et al., 1984; Hickman-
Brenner et al., 1985; Yagu¨e Mun˜oz et al., 1989). Biochemically, Y. regensburgei closely resembles Hafnia 
alvei and Salmonella enterica (Stock et al., 2004); nevertheless, DNA relatedness values and other studies have 
showed that they are separate species (Kosako et al., 1984; Hickman-Brenner et al., 1985).  The clinical 
importance of Y. regensburgei as a human pathogen is not well definite. This may be attributed to a lack of 
resources in routine clinical laboratories for its identification. Only five clinical cases of human infection have 
been reported  worldwide. In  1993, an isolate was isolated  from a left-knee wound. The isolate was initially 
forwarded to the local county public health laboratory and then to the Microbial Diseases Laboratory, where it 
was identified as Y. regensburgei. In 1994,  gastrointestinal bleeding case pateint where blood culture was done 
and a gram-negative rod was identified. The strain was identified by the local laboratory as a possible 
Salmonella sp. Further laboratory diagnosis by the Microbial Diseases Laboratory using an alcohol-treated  
antigen shown no agglutination in Salmonella antiserum. Biochemical analysis identified this strain as Y 
regensburgei (Abbott and  Janda, 1994), the bacterium were isolated from venous ulcer wound infection  
(Fajardo Olivares et al., 2005), abdominal abscess and septic shock (Fill and  Stephens, 2010) , soft tissue 
infection with bacteraemia (Lo et al., 2011) and  Sarika et al. (2013) present a case report of a bloodstream 
infection due to Y. regensburgei from India. An association between Y. regensburgei  infection and some form of 
immune suppression has been observed  in all these reports, such as alcohol intake, chronic renal failure, 
diabetes mellitus, adenocarcinoma and the use of steroids and immunosuppressive agents.In return for this 
current study revealed that  the identified bacterium was isolated from chronic renal infection . Furthermore, all 
cases were reported in adults or elderly patients. Isolation of this species from water from wells, insect intestines, 
human upper respiratory tract, faeces and urine may suggest its ability to survive in these locations; however, the 
source and route of transmission is unclear (Kosako et al., 1984; Hickman-Brenner et al., 1985). 
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Conclusion  
Our conclusion that  attention must drive towards the emerging of new agent of urinary tract infection 
represented by Yokenella regensburgei other than the common known agents which could indicate the shifting in 
pathogenicity of these agent .   
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